NL176365C - Werkwijze ter bereiding van aminoderivaten van pyrazolo/3.4-b/pyridine-5-carbonzuren en esters en zouten daarvan en werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat, dat deze verbindingen als actief bestanddeel bevat. - Google Patents

Werkwijze ter bereiding van aminoderivaten van pyrazolo/3.4-b/pyridine-5-carbonzuren en esters en zouten daarvan en werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat, dat deze verbindingen als actief bestanddeel bevat.

Info

Publication number
NL176365C
NL176365C NLAANVRAGE7210701,A NL7210701A NL176365C NL 176365 C NL176365 C NL 176365C NL 7210701 A NL7210701 A NL 7210701A NL 176365 C NL176365 C NL 176365C
Authority
NL
Netherlands
Prior art keywords
preparation
pyrazolo
pyridine
esters
salts
Prior art date
Application number
NLAANVRAGE7210701,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7210701A (US07579456-20090825-P00002.png
NL176365B (nl
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL7210701A publication Critical patent/NL7210701A/xx
Publication of NL176365B publication Critical patent/NL176365B/xx
Application granted granted Critical
Publication of NL176365C publication Critical patent/NL176365C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NLAANVRAGE7210701,A 1971-08-05 1972-08-04 Werkwijze ter bereiding van aminoderivaten van pyrazolo/3.4-b/pyridine-5-carbonzuren en esters en zouten daarvan en werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat, dat deze verbindingen als actief bestanddeel bevat. NL176365C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16953671A 1971-08-05 1971-08-05

Publications (3)

Publication Number Publication Date
NL7210701A NL7210701A (US07579456-20090825-P00002.png) 1973-02-07
NL176365B NL176365B (nl) 1984-11-01
NL176365C true NL176365C (nl) 1985-04-01

Family

ID=22616112

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7210701,A NL176365C (nl) 1971-08-05 1972-08-04 Werkwijze ter bereiding van aminoderivaten van pyrazolo/3.4-b/pyridine-5-carbonzuren en esters en zouten daarvan en werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat, dat deze verbindingen als actief bestanddeel bevat.

Country Status (17)

Country Link
US (1) US3755340A (US07579456-20090825-P00002.png)
JP (3) JPS5637237B2 (US07579456-20090825-P00002.png)
AR (2) AR199280A1 (US07579456-20090825-P00002.png)
AU (1) AU462839B2 (US07579456-20090825-P00002.png)
BE (1) BE787249A (US07579456-20090825-P00002.png)
CA (1) CA997350A (US07579456-20090825-P00002.png)
CH (3) CH553798A (US07579456-20090825-P00002.png)
DE (1) DE2237765A1 (US07579456-20090825-P00002.png)
ES (2) ES405553A1 (US07579456-20090825-P00002.png)
FR (1) FR2150737B1 (US07579456-20090825-P00002.png)
GB (1) GB1402172A (US07579456-20090825-P00002.png)
HU (1) HU164519B (US07579456-20090825-P00002.png)
IE (1) IE36600B1 (US07579456-20090825-P00002.png)
NL (1) NL176365C (US07579456-20090825-P00002.png)
PH (2) PH10047A (US07579456-20090825-P00002.png)
YU (1) YU35138B (US07579456-20090825-P00002.png)
ZA (1) ZA724745B (US07579456-20090825-P00002.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835144A (en) * 1972-06-16 1974-09-10 Squibb & Sons Inc Amino derivatives of (4,3-c pyrazolopyridine cabroxylic acids and esters
US3984422A (en) * 1972-06-16 1976-10-05 E. R. Squibb & Sons, Inc. Amino derivatives of [4,3-c]pyrazolopyridine carboxylic acids and esters
US3957782A (en) * 1974-12-16 1976-05-18 E. R. Squibb & Sons, Inc. Pyrazolo [3,4-b]pyrazine-5-carboxylic acids, esters, nitriles and amides
US3996233A (en) * 1975-02-10 1976-12-07 E. R. Squibb & Sons, Inc. Amino derivatives of imidazo[4,5-b]pyridines
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
CA1071207A (en) * 1975-04-30 1980-02-05 Theodor Denzel 4-amino derivatives of 2h-pyrazolo (3,4-b) pyridine-5-carboxylic acids and esters
US3985760A (en) * 1975-09-11 1976-10-12 E. R. Squibb & Sons, Inc. Amino derivatives of 6-phenylisoxazolo[5,4-b]pyridines
JPS531041U (US07579456-20090825-P00002.png) * 1976-06-22 1978-01-07
US4364948A (en) * 1981-09-28 1982-12-21 Ici Americas Inc. Pyrazolo[3,4-b]pyridine compounds
GB8310266D0 (en) * 1982-05-12 1983-05-18 Ici America Inc Pyrazolopyridine compounds
US4552883A (en) * 1982-06-15 1985-11-12 Ici Americas Inc. Pyrazolo[3,4-b]pyridine carboxylic acid esters and their pharmaceutical use
IT1154024B (it) * 1982-09-22 1987-01-21 Lepetit Spa Derivati pridinici e procedimento per la loro produzione
GB8425104D0 (en) * 1984-10-04 1984-11-07 Ici America Inc Amide derivatives
JPH0522500Y2 (US07579456-20090825-P00002.png) * 1984-12-27 1993-06-10
JPS61113659U (US07579456-20090825-P00002.png) * 1984-12-28 1986-07-18
DE3683541D1 (de) 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
JPS62103137U (US07579456-20090825-P00002.png) * 1985-12-20 1987-07-01
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
JPS63188572U (US07579456-20090825-P00002.png) * 1987-05-28 1988-12-02
GB9716161D0 (en) 1997-08-01 1997-10-08 Zeneca Ltd Process
ATE355841T1 (de) * 1997-12-13 2007-03-15 Bristol Myers Squibb Co Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer
US6326379B1 (en) 1998-09-16 2001-12-04 Bristol-Myers Squibb Co. Fused pyridine inhibitors of cGMP phosphodiesterase
PL375993A1 (en) * 2002-09-16 2005-12-12 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
GB0230045D0 (en) 2002-12-23 2003-01-29 Glaxo Group Ltd Compounds
US20070111995A1 (en) * 2003-12-19 2007-05-17 Allen David G Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors
GB0405937D0 (en) * 2004-03-16 2004-04-21 Glaxo Group Ltd Compounds
WO2005090352A1 (en) * 2004-03-16 2005-09-29 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
WO2008079839A1 (en) * 2006-12-20 2008-07-03 Astrazeneca Ab Compounds and uses thereof
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
TW200908968A (en) 2007-05-29 2009-03-01 Sgx Pharmaceuticals Inc Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
UY31635A1 (es) * 2008-02-06 2009-08-31 Farmacóforos duales-antagonistas muscarínicos de pde4
UY31637A1 (es) * 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
AR070563A1 (es) * 2008-02-06 2010-04-21 Glaxo Group Ltd Compuesto de un biciclo condensado pirazol-piridin-amina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de enfermedades respiratorias.

Also Published As

Publication number Publication date
NL7210701A (US07579456-20090825-P00002.png) 1973-02-07
AU4514672A (en) 1974-02-07
ES413941A1 (es) 1976-06-01
GB1402172A (en) 1975-08-06
BE787249A (fr) 1973-02-05
US3755340A (en) 1973-08-28
AU462839B2 (en) 1975-07-10
CH553798A (fr) 1974-09-13
CH553800A (fr) 1974-09-13
FR2150737B1 (US07579456-20090825-P00002.png) 1975-06-20
CA997350A (en) 1976-09-21
AR199280A1 (es) 1974-08-23
ES405553A1 (es) 1975-07-01
ZA724745B (en) 1973-04-25
DE2237765A1 (de) 1973-02-08
AR199294A1 (es) 1974-08-23
JPS5622768A (en) 1981-03-03
YU35138B (en) 1980-09-25
IE36600L (en) 1973-02-05
YU202072A (en) 1980-03-15
HU164519B (US07579456-20090825-P00002.png) 1974-02-28
IE36600B1 (en) 1976-12-08
JPS5622784A (en) 1981-03-03
PH10047A (en) 1976-07-27
PH13781A (en) 1980-09-26
JPS4826796A (US07579456-20090825-P00002.png) 1973-04-09
JPS5745440B2 (US07579456-20090825-P00002.png) 1982-09-28
JPS5637237B2 (US07579456-20090825-P00002.png) 1981-08-29
FR2150737A1 (US07579456-20090825-P00002.png) 1973-04-13
JPS597703B2 (ja) 1984-02-20
CH549590A (fr) 1974-05-31
NL176365B (nl) 1984-11-01

Similar Documents

Publication Publication Date Title
NL176365C (nl) Werkwijze ter bereiding van aminoderivaten van pyrazolo/3.4-b/pyridine-5-carbonzuren en esters en zouten daarvan en werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat, dat deze verbindingen als actief bestanddeel bevat.
NL170140C (nl) Werkwijze ter bereiding van farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van 1,4-dihydropyridine 3,5-dicarbonzuuresters.
NL174547B (nl) Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
YU36681B (en) Process for preparing 4-phenoxy-phenoxyalkane carboxylic acid derivatives
NO741617L (no) Fremgangsmåte for fremstilling av aminosyrene D-(-)-alanin og D-(-)-valin.
NL179729C (nl) Werkwijze ter bereiding van farmaceutische preparaten op basis van 1h-indazool-3-carbonzuurderivaten alsmede werkwijze ter bereiding van deze 1h-indazool-3-carbonzuurderivaten.
CA979437A (en) 15-oxoprostanoic acid derivatives and process for the preparation thereof
AU460457B2 (en) Polyamides modified with adipic acid and process for their preparation
NL173400C (nl) Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren.
NL176460B (nl) Werkwijze ter bereiding respektievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare triazolodiazepine-verbindingen.
CY916A (en) New process for the preparation of (3-benzoylphenyl) alkanoic acids
NL170731C (nl) Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat met antidepressieve werking dat een 1-aryl-1-fenyl-3-dimethylamino-propeen-1-derivaat of een therapeutisch aanvaardbaar zuuradditiezout daarvan bevat en werkwijze voor het bereiden van deze 1-aryl-1-fenyl-3-dimethylamino-propeen-1-derivaten of de zuuradditiezouten daarvan.
NL149082B (nl) Werkwijze ter bereiding van farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van daarvoor geschikte thiazolino (3,2-a)-5-pyrimidinonderivaten.
NL179205C (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur.
NL176366C (nl) Werkwijze ter bereiding van 4,9,11-trieensteroidverbindingen, werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.
CA890944A (en) Process for the preparation of aliphatic perfluoro-carboxylic acids and the derivatives thereof
CH546783A (de) Verfahren zur herstellung von penicilloinsaeurederivate.
CA889860A (en) Process for the preparation of nitrogen-containing derivatives of acids
GB1408722A (en) Process for the preparation of an -ar-alkane carboxylic acid
CA980346A (en) Carboxylic acid derivatives and method for the preparation thereof
CS180697B1 (en) Method of preparing difluoroacetic acid and derivatives thereof,especially esters
CA897691A (en) Process for the production of 1,5,6, 10b-tetrahydro-3h-oxazolo(4-3-a)-isoquinoline derivatives and acid addition salts thereof
AU467163B2 (en) 8. 12-diisoprostanoic acid derivatives and process for their preparation
CA871756A (en) Process for the preparation of adipic acid
NL7504799A (nl) Werkwijze voor de bereiding van een therapeu- tisch werkzaam aminozuurderivaat.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee